"Bioasis has 2 of those top ten drugs in its pipeline, both likely to cross the BBB in efficacious quantities and both protected by long term patent protections.

xB3-001: Herceptin (trastuzumab): HER2+ Breast cancer and brain metastases 
xB3-002: Avastin (bevacizumab): Glioblastoma"

https://stockhouse.com/companies/bullboard?symbol=v.bti&postid=30037307

Koo